Bodenrader Mark

Insider profile

Performance

Overall performance
1.1

Performance over holding periods
1.1
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Bodenrader Mark's trades of Cerevel Therapeutics Holdings Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-12-21 2023-12-20 S Sale
28,948 +16.3%
55.05
US$793,727
28,948 +16.3% 55.05 US$793,727
2023-06-05 2023-06-02 PrS Proposed sale
40,305
302.27
US$761,944
40,305 302.27 US$761,944
2023-06-05 2023-06-02 PlS Planned sale
85,976 -9.6%
51.13
US$3,777,288
85,976 -9.6% 51.13 US$3,777,288